https://stockbrief.blog/2026/06/23/%e0%b9%80%e0%b8%88%e0%b8%b2%e0%b8%b0%e0%b8%a5%e0%b8%b6%e0%b8%81%e0%b8%ab%e0%b8%b8%e0%b9%89%e0%b8%99-oruka-therapeutics-%e0%b8%9e%e0%b8%b8%e0%b9%88%e0%b8%87%e0%b9%81%e0%b8%a3%e0%b8%87-%e0%b8%a7/StockBriefko2026-06-23T02:15:58+00:00เจาะลึกหุ้น Oruka Therapeutics พุ่งแรง วอลุ่มแน่นกว่าปกติ 2.6 เท่า พร้อมบทวิเคราะห์จากวอลล์สตรีทhttps://stockbrief.blog/wp-content/uploads/2026/06/20260623_051423_orka_chart_1_price-3.png?w=150https://stockbrief.blog/2026/06/23/%e0%b8%aa%e0%b9%88%e0%b8%ad%e0%b8%87%e0%b8%a3%e0%b8%b2%e0%b8%84%e0%b8%b2%e0%b9%80%e0%b8%9b%e0%b9%89%e0%b8%b2%e0%b8%ab%e0%b8%a1%e0%b8%b2%e0%b8%a2-apogee-therapeutics-%e0%b8%aa%e0%b8%b0%e0%b8%97/StockBriefko2026-06-23T01:55:58+00:00ส่องราคาเป้าหมาย Apogee Therapeutics สะท้อนความคาดหวังของ Wall Street แล้วหรือยังhttps://stockbrief.blog/wp-content/uploads/2026/06/20260623_051423_apge_chart_1_price-3.png?w=150https://stockbrief.blog/2026/06/23/%e0%b9%80%e0%b8%88%e0%b8%b2%e0%b8%b0%e0%b8%a5%e0%b8%b6%e0%b8%81-definium-therapeutics-%e0%b8%ab%e0%b8%b8%e0%b9%89%e0%b8%99%e0%b8%9e%e0%b8%b8%e0%b9%88%e0%b8%87%e0%b9%80%e0%b8%9e%e0%b8%a3%e0%b8%b2/StockBriefko2026-06-23T01:35:58+00:00เจาะลึก Definium Therapeutics หุ้นพุ่งเพราะอะไร พร้อมวิเคราะห์แนวรับ-แนวต้านที่น่าซื้อhttps://stockbrief.blog/wp-content/uploads/2026/06/20260623_051423_dftx_chart_1_price-3.png?w=150https://stockbrief.blog/2026/06/23/co-phieu-space-exploration-%e0%b9%80%e0%b8%97%ed%81%ac%eb%86%80%eb%a1%9c%ec%a7%80-phuc-hoi-xac-nhan-khoi-luong-giao-dich-gap-0-6-lan/StockBriefko2026-06-23T01:15:58+00:00Cổ phiếu Space Exploration เท크놀로지 phục hồi, xác nhận khối lượng giao dịch gấp 0.6 lầnhttps://stockbrief.blog/wp-content/uploads/2026/06/20260623_051423_spcx_chart_1_price-2.png?w=150https://stockbrief.blog/2026/06/23/co-phieu-oruka-therapeutics-tang-manh-phan-tich-tu-pho-wall-va-kiem-tra-khoi-luong-giao-dich-gap-2-6-lan/StockBriefko2026-06-23T00:55:58+00:00Cổ phiếu Oruka Therapeutics tăng mạnh, phân tích từ Phố Wall và kiểm tra khối lượng giao dịch gấp 2.6 lầnhttps://stockbrief.blog/wp-content/uploads/2026/06/20260623_051423_orka_chart_1_price-2.png?w=150https://stockbrief.blog/2026/06/23/gia-muc-tieu-cua-apogee-therapeutics-lieu-da-phan-anh-ky-vong-phan-tich-tu-pho-wall/StockBriefko2026-06-23T00:35:58+00:00Giá mục tiêu của Apogee Therapeutics, liệu đã phản ánh kỳ vọng phân tích từ Phố Wall?https://stockbrief.blog/wp-content/uploads/2026/06/20260623_051423_apge_chart_1_price-2.png?w=150https://stockbrief.blog/2026/06/23/ly-do-co-phieu-definium-therapeutics-tang-va-vung-mua-hop-ly/StockBriefko2026-06-23T00:15:58+00:00Lý do cổ phiếu Definium Therapeutics tăng và vùng mua hợp lýhttps://stockbrief.blog/wp-content/uploads/2026/06/20260623_051423_dftx_chart_1_price-2.png?w=150https://stockbrief.blog/2026/06/23/harga-saham-space-exploration-%ed%85%8c%ed%81%ac%eb%86%80%eb%a1%9c%ec%a7%80-memantul-konfirmasi-volume-perdagangan-0-6-kali/StockBriefko2026-06-22T23:55:58+00:00Harga Saham Space Exploration 테크놀로지 Memantul, Konfirmasi Volume Perdagangan 0.6 Kalihttps://stockbrief.blog/wp-content/uploads/2026/06/20260623_051423_spcx_chart_1_price-1.png?w=150https://stockbrief.blog/2026/06/23/analisis-saham-oruka-therapeutics-naik-wall-street-soroti-volume-perdagangan-melonjak-2-6-kali-lipat/StockBriefko2026-06-22T23:35:58+00:00Analisis Saham Oruka Therapeutics Naik, Wall Street Soroti Volume Perdagangan Melonjak 2.6 Kali Lipathttps://stockbrief.blog/wp-content/uploads/2026/06/20260623_051423_orka_chart_1_price-1.png?w=150https://stockbrief.blog/2026/06/23/target-harga-apogee-therapeutics-apakah-ekspektasi-analisis-wall-street-sudah-tercermin/StockBriefko2026-06-22T23:15:58+00:00Target Harga Apogee Therapeutics, Apakah Ekspektasi Analisis Wall Street Sudah Tercermin?https://stockbrief.blog/wp-content/uploads/2026/06/20260623_051423_apge_chart_1_price-1.png?w=150https://stockbrief.blog/2026/06/23/alasan-saham-definium-therapeutics-naik-dan-area-beli-yang-tepat/StockBriefko2026-06-22T22:55:58+00:00Alasan Saham Definium Therapeutics Naik dan Area Beli yang Tepathttps://stockbrief.blog/wp-content/uploads/2026/06/20260623_051423_dftx_chart_1_price-1.png?w=150https://stockbrief.blog/2026/06/23/space-exploration-technologies-stock-rebounds-on-0-6x-trading-volume/StockBriefko2026-06-22T22:35:58+00:00Space Exploration Technologies Stock Rebounds on 0.6x Trading Volumehttps://stockbrief.blog/wp-content/uploads/2026/06/20260623_051423_spcx_chart_1_price.png?w=150https://stockbrief.blog/2026/06/23/oruka-therapeutics-stock-rises-wall-street-analysis-and-2-6x-volume-surge/StockBriefko2026-06-22T22:15:58+00:00Oruka Therapeutics Stock Rises: Wall Street Analysis and 2.6x Volume Surgehttps://stockbrief.blog/wp-content/uploads/2026/06/20260623_051423_orka_chart_1_price.png?w=150https://stockbrief.blog/2026/06/23/apogee-therapeutics-price-target-has-wall-streets-optimism-already-been-priced-in/StockBriefko2026-06-22T21:55:58+00:00Apogee Therapeutics Price Target: Has Wall Street’s Optimism Already Been Priced In?https://stockbrief.blog/wp-content/uploads/2026/06/20260623_051423_apge_chart_1_price.png?w=150https://stockbrief.blog/2026/06/23/why-definium-therapeutics-is-rising-and-is-it-a-buy/StockBriefko2026-06-22T21:35:58+00:00Why Definium Therapeutics Is Rising and Is It a Buy?https://stockbrief.blog/wp-content/uploads/2026/06/20260623_051423_dftx_chart_1_price.png?w=150